Non-Hodgkin Lymphoma
About
Mappings
NCI Thesaurus: Non-Hodgkin Lymphoma (coding:ncit:C3211)
OncoTree: Non-Hodgkin Lymphoma (coding:oncotree:NHL)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Rituximab | |
| FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Prednisolone, Rituximab, Vincristine | |
| EMA (1) FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine | |
| FDA (2) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Fludarabine, Mitoxantrone, Rituximab | |
| FDA (4) | CD20 + | Non-Hodgkin Lymphoma | Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine | |
| EMA (1) | CD20 + | Non-Hodgkin Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine |